▶ 調査レポート

世界の筋骨格障害幹細胞療法市場予測（～2024年）
• 英文タイトル：Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の筋骨格障害幹細胞療法市場予測（～2024年） / Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024 / B-GIR09D2355資料のイメージです。• レポートコード：B-GIR09D2355
• 出版社/出版日：GlobalInfoResearch / 2019年9月11日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Multi User￥772,560 (USD5,220)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートは、筋骨格障害幹細胞療法の世界市場について調べ、まとめました。種類別セグメントは、同種、自己等、用途別セグメントは、筋疾患、骨格疾患等に区分しました。筋骨格障害幹細胞療法の世界市場概観、メーカー動向、メーカー別筋骨格障害幹細胞療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・筋骨格障害幹細胞療法の市場概観
・筋骨格障害幹細胞療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・筋骨格障害幹細胞療法の企業別販売動向、市場シェア、市場集中度、競争動向
・筋骨格障害幹細胞療法の世界市場規模
・筋骨格障害幹細胞療法の北米市場分析（アメリカ、カナダ、メキシコ等）
・筋骨格障害幹細胞療法のアメリカ市場規模推移
・筋骨格障害幹細胞療法のカナダ市場規模推移
・筋骨格障害幹細胞療法のメキシコ市場規模推移
・筋骨格障害幹細胞療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・筋骨格障害幹細胞療法のドイツ市場規模推移
・筋骨格障害幹細胞療法のイギリス市場規模推移
・筋骨格障害幹細胞療法のロシア市場規模推移
・筋骨格障害幹細胞療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・筋骨格障害幹細胞療法の日本市場規模推移
・筋骨格障害幹細胞療法の中国市場規模推移
・筋骨格障害幹細胞療法の韓国市場規模推移
・筋骨格障害幹細胞療法のインド市場規模推移
・筋骨格障害幹細胞療法の東南アジア市場規模推移
・筋骨格障害幹細胞療法の南米市場分析（ブラジル、アルゼンチン等）
・筋骨格障害幹細胞療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・筋骨格障害幹細胞療法の種類別分析/販売量、売上、市場シェア（同種、自己）
・筋骨格障害幹細胞療法の用途別分析/市場規模（筋疾患、骨格疾患）
・筋骨格障害幹細胞療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・筋骨格障害幹細胞療法の販売チャネル・代理店・貿易業者・ディーラー分析

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy.

Scope of the Report:
The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Musculoskeletal Disorder Stem Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Musculoskeletal Disorder Stem Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Musculoskeletal Disorder Stem Cell Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
Osiris Therapeutics
NuVasive
Takeda (TiGenix)
Medi-post

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Allogeneic
Autologous

Market Segment by Applications, can be divided into
Muscle disease
Skeletal disease

レポート目次

Table of Contents

1 Musculoskeletal Disorder Stem Cell Therapy Market Overview
1.1 Product Overview and Scope of Musculoskeletal Disorder Stem Cell Therapy
1.2 Classification of Musculoskeletal Disorder Stem Cell Therapy by Types
1.2.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Types in 2018
1.2.3 Allogeneic
1.2.4 Autologous
1.3 Global Musculoskeletal Disorder Stem Cell Therapy Market by Application
1.3.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Muscle disease
1.3.3 Skeletal disease
1.4 Global Musculoskeletal Disorder Stem Cell Therapy Market by Regions
1.4.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Musculoskeletal Disorder Stem Cell Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Musculoskeletal Disorder Stem Cell Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Musculoskeletal Disorder Stem Cell Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Musculoskeletal Disorder Stem Cell Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Musculoskeletal Disorder Stem Cell Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Musculoskeletal Disorder Stem Cell Therapy (2014-2024)
2 Manufacturers Profiles
2.1 Osiris Therapeutics
2.1.1 Business Overview
2.1.2 Musculoskeletal Disorder Stem Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 NuVasive
2.2.1 Business Overview
2.2.2 Musculoskeletal Disorder Stem Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 NuVasive Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Takeda (TiGenix)
2.3.1 Business Overview
2.3.2 Musculoskeletal Disorder Stem Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Medi-post
2.4.1 Business Overview
2.4.2 Musculoskeletal Disorder Stem Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medi-post Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Musculoskeletal Disorder Stem Cell Therapy Market Competition, by Players
3.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Musculoskeletal Disorder Stem Cell Therapy Players Market Share
3.2.2 Top 10 Musculoskeletal Disorder Stem Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Musculoskeletal Disorder Stem Cell Therapy Market Size by Regions
4.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue and Market Share by Regions
4.2 North America Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
5 North America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries
5.1 North America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
5.2 USA Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
6 Europe Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries
6.1 Europe Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
6.2 Germany Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
6.4 France Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries
7.1 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
7.2 China Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
7.5 India Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
8 South America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries
8.1 South America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
8.2 Brazil Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Musculoskeletal Disorder Stem Cell Therapy by Countries
9.1 Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
10 Global Musculoskeletal Disorder Stem Cell Therapy Market Segment by Type
10.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Musculoskeletal Disorder Stem Cell Therapy Market Forecast by Type (2019-2024)
10.3 Allogeneic Revenue Growth Rate (2014-2024)
10.4 Autologous Revenue Growth Rate (2014-2024)
11 Global Musculoskeletal Disorder Stem Cell Therapy Market Segment by Application
11.1 Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Application (2014-2019)
11.2 Musculoskeletal Disorder Stem Cell Therapy Market Forecast by Application (2019-2024)
11.3 Muscle disease Revenue Growth (2014-2019)
11.4 Skeletal disease Revenue Growth (2014-2019)
12 Global Musculoskeletal Disorder Stem Cell Therapy Market Size Forecast (2019-2024)
12.1 Global Musculoskeletal Disorder Stem Cell Therapy Market Size Forecast (2019-2024)
12.2 Global Musculoskeletal Disorder Stem Cell Therapy Market Forecast by Regions (2019-2024)
12.3 North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
12.6 South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Musculoskeletal Disorder Stem Cell Therapy Picture
Table Product Specifications of Musculoskeletal Disorder Stem Cell Therapy
Table Global Musculoskeletal Disorder Stem Cell Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Types in 2018
Figure Allogeneic Picture
Figure Autologous Picture
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Application (2014-2024)
Figure Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Applications in 2018
Figure Muscle disease Picture
Figure Skeletal disease Picture
Table Global Market Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Type and Applications
Table Osiris Therapeutics Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table NuVasive Basic Information, Manufacturing Base and Competitors
Table NuVasive Musculoskeletal Disorder Stem Cell Therapy Type and Applications
Table NuVasive Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda (TiGenix) Basic Information, Manufacturing Base and Competitors
Table Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Type and Applications
Table Takeda (TiGenix) Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Medi-post Basic Information, Manufacturing Base and Competitors
Table Medi-post Musculoskeletal Disorder Stem Cell Therapy Type and Applications
Table Medi-post Musculoskeletal Disorder Stem Cell Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Players (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Players in 2017
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share in 2018
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Regions in 2018
Figure North America Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South America Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table North America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
Table North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries in 2018
Figure USA Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table Europe Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries in 2018
Figure Germany Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UK Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure France Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries in 2018
Figure China Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure India Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table South America Musculoskeletal Disorder Stem Cell Therapy Revenue by Countries (2014-2019)
Table South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries in 2018
Figure Brazil Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Musculoskeletal Disorder Stem Cell Therapy Revenue and Growth Rate (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Type (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Type (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Type in 2019
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Forecast by Type (2019-2024)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Market Share Forecast by Type (2019-2024)
Figure Global Allogeneic Revenue Growth Rate (2014-2019)
Figure Global Autologous Revenue Growth Rate (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue by Application (2014-2019)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Application (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Application (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Share by Application in 2019
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue Forecast by Application (2019-2024)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Market Share Forecast by Application (2019-2024)
Figure Global Muscle disease Revenue Growth Rate (2014-2019)
Figure Global Skeletal disease Revenue Growth Rate (2014-2019)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Musculoskeletal Disorder Stem Cell Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Musculoskeletal Disorder Stem Cell Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
Figure Europe Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
Figure South America Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Musculoskeletal Disorder Stem Cell Therapy Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 世界の季節性情動障害光療法市場予測（～2024年）
    Global Seasonal Affective Disorder Light Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4277 2019年9月18日 122Pages
    本調査レポートは、季節性情動障害光療法の世界市場について調べ、まとめました。種類別セグメントは、光療法ランプ、光療法目覚まし時計等、用途別セグメントは、病院、診療所、医学研究センター、その他等に区分しました。季節性情動障害光療法の世界市場概観、企業動向、企業別季節性情動障害光療法シェア、市場規模推移...
  • 胚性幹細胞市場：世界及び中国市場分析・予測（～2024年）
    Embryonic Stem Cell Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT7868 2019年10月1日 139Pages
    「胚性幹細胞市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における胚性幹細胞市場について調査・分析したレポートで、胚性幹細胞の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・胚性幹細胞産業の概要
    ・胚性幹細胞の製造技術分析
    ・主要...
  • 幹細胞アッセイ市場：世界及び中国市場分析・予測（～2024年）
    Stem Cell Assay Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT6119 2019年10月11日 144Pages
    「幹細胞アッセイ市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における幹細胞アッセイ市場について調査・分析したレポートで、幹細胞アッセイの世界市場動向、市場規模、主要企業情報などが含まれています。幹細胞アッセイのタイプ別には、生存率、浄化、識別に分けて分析し、地域別には、アメリカ...
  • 造血幹細胞市場：世界及び中国市場分析・予測（～2024年）
    Hematopoietic Stem Cell Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT8107 2019年10月1日 146Pages
    「造血幹細胞市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における造血幹細胞市場について調査・分析したレポートで、造血幹細胞の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・造血幹細胞産業の概要
    ・造血幹細胞の製造技術分析
    ・主要...
  • ヒト胚性幹細胞市場：世界及び中国市場分析・予測（～2024年）
    Human Embryonic Stem Cell Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT8168 2019年10月1日 139Pages
    「ヒト胚性幹細胞市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるヒト胚性幹細胞市場について調査・分析したレポートで、ヒト胚性幹細胞の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・ヒト胚性幹細胞産業の概要
    ・ヒト胚性幹細胞の製造技術分析...
  • 幹細胞臍帯血市場：世界及び中国市場分析・予測（～2024年）
    Stem Cell Umbilical Cord Blood Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT6120 2019年10月11日 144Pages
    「幹細胞臍帯血市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における幹細胞臍帯血市場について調査・分析したレポートで、幹細胞臍帯血の世界市場動向、市場規模、主要企業情報などが含まれています。幹細胞臍帯血のタイプ別には、公共臍帯血バンク、民間臍帯血バンクに分けて分析し、地域別には、...
  • 世界の組換え細胞培養サプリメント市場予測（～2024年）
    Global Recombinant Cell Culture Supplements Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
    B-GIR09D2909 2019年9月11日 124Pages
    本調査レポートは、組換え細胞培養サプリメントの世界市場について調べ、まとめました。種類別セグメントは、組換えアルブミン、組換えインスリン、組換え上皮成長因子、組換えトランスフェリン、その他等、用途別セグメントは、幹細胞及び再生医療、バイオプロダクション、学術及び研究アプリケーション等に区分しました。...
  • 世界のセルバンキングアウトソーシング市場予測（～2024年）
    Global Cell Banking Outsourcing Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
    B-GIR09D0738 2019年9月4日 139Pages
    本調査レポートは、セルバンキングアウトソーシングの世界市場について調べ、まとめました。種類別セグメントは、幹セルバンキング、非幹セルバンキング等、用途別セグメントは、セルバンクストレージ、セルバンクの準備等に区分しました。セルバンキングアウトソーシングの世界市場概観、メーカー動向、メーカー別セルバン...
  • 世界の代謝障害治療薬市場予測（～2024年）
    Global Metabolic Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4128 2019年9月18日 138Pages
    本調査レポートは、代謝障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、リソソーム蓄積症、糖尿病、肥満、遺伝性代謝障害、高コレステロール血症等、用途別セグメントは、経口、非経口、その他等に区分しました。代謝障害治療薬の世界市場概観、企業動向、企業別代謝障害治療薬シェア、市場規模推移...
  • 世界のCAR T細胞免疫療法市場予測（～2024年）
    Global CAR T-Cell Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3834 2019年9月18日 136Pages
    本調査レポートは、CAR T細胞免疫療法の世界市場について調べ、まとめました。種類別セグメントは、単独療法、併用療法等、用途別セグメントは、血液悪性腫瘍、固形悪性腫瘍等に区分しました。CAR T細胞免疫療法の世界市場概観、企業動向、企業別CAR T細胞免疫療法シェア、市場規模推移、市場規模予測（20...